Buying shares in this small-cap biotech hasn't made long-term investors rich -- at least, not yet.
Buy shares of a company that isn't profitable yet and doesn't even have consistent revenue. Inovio Pharmaceuticals (NASDAQ: INO) definitely fits the bill of a company that isn't generating a profit r
On Friday, shares of Inovio Pharmaceuticals (NASDAQ: INO) saw unusual options activity. After the option alert, the stock price moved up to $15.5. * Sentiment: BEARISH * Option Type: SWEEP * Trade
2020 is turning out to be a tale of two halves for Inovio Pharmaceuticals (INO).The vaccine maker's valuation increased 10-fold between January and early July, backed by vigorous coronavirus tailwinds

Why Inovio Pharmaceuticals Stock Is Up Today

04:42pm, Thursday, 13'th Aug 2020
After a rough week on the stock market for the biotech company, investors finally think the price is right.
Inovio’s Q2 earnings and lingering questions about its INO-4800 vaccine are combining for a big drop for INOP stock. The post Inovio Pharmaceuticals Shares Drop, Get a Downgrade appeared first on In

Why Inovio Pharmaceuticals Stock Is Up Today

12:42pm, Thursday, 13'th Aug 2020
After a rough week on the stock market for the biotech company, investors finally think the price is right.

Is Inovio Pharmaceuticals Stock a Buy?

12:33pm, Thursday, 13'th Aug 2020
Negative results from clinical trials or regulatory roadblocks can send shares of these companies plunging. On the other hand, investing in the right clinical-stage biotech stock can reap life-changi
I demonstrate why Pfizer is the best choice for dividend investors playing the Covid-19 vaccine theme.
Its experimental coronavirus vaccine has some of the best clinical data among the 167 candidates in development.
If you've been following the race to discover a coronavirus vaccine, it won't be any shock to hear that both Moderna Therapeutics (NASDAQ: MRNA) and Inovio Pharmaceuticals (NASDAQ: INO) are among the

Is Inovio Pharmaceuticals Stock a Buy?

08:33am, Thursday, 13'th Aug 2020
Could this biotech stock be a major winner down the road?
Its experimental coronavirus vaccine has some of the best clinical data among the 167 candidates in development.

Why Inovio Stock Is Sinking Again Today

04:07pm, Wednesday, 12'th Aug 2020
Shares of Inovio Pharmaceuticals (NASDAQ: INO) were sinking 12.2% lower as of 11:16 a.m. EDT on Wednesday. This marked the second consecutive day of steep declines for the stock after Inovio's Q2 upd
During Q2, Inovio Pharmaceuticals's (NASDAQ: INO) reported sales totaled $267.19 thousand. Despite a 15.17% in earnings, the company posted a loss of $29.06 million. Inovio Pharmaceuticals collected $
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE